Clinical Trials Directory

Trials / Sponsors / Fulcrum Therapeutics

Fulcrum Therapeutics

Industry · 10 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationOpen-Label Extension Study to Pioneer Study 6058-SCD-101
Sickle Cell Disease
Phase 22026-03-30
RecruitingSingle-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease
Sickle Cell Disease
Phase 12025-12-13
TerminatedEfficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 32022-06-16
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
Sickle Cell Disease, Sickle Cell Anemia
Phase 12021-12-13
CompletedRelative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets
Healthy Adult Subjects
Phase 12021-08-19
CompletedSafety, Tolerability and Pharmacokinetics of FTX-6058
Healthy Adult Subjects, Sickle Cell Disease
Phase 12020-10-26
TerminatedLosmapimod Safety and Efficacy in COVID-19
COVID-19
Phase 32020-08-28
TerminatedEfficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With
Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 22020-02-13
TerminatedEvaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod fo
Facioscapulohumeral Muscular Dystrophy 1
Phase 22019-08-23
CompletedEfficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)
Facioscapulohumeral Muscular Dystrophy (FSHD)
Phase 22019-08-09